Emergency care first
Time-critical treatment and rehabilitation
Emergency brain imaging, reperfusion when eligible, hemorrhage management, prevention of another stroke, and multidisciplinary rehabilitation remain the foundation we build around.
Recovery, planned with precision
Stem cell therapy for stroke recovery in Istanbul
Once you are medically stable, our Istanbul program pairs cell-therapy protocols with intensive rehabilitation and physician monitoring to support your recovery goals.
Conceptual biological visualization
Evidence status
What the evidence can support now
Our recovery protocols
Product matched to your recovery phase
We work with defined IV multipotent cells, marrow-cell preparations, and neural-product research suited to your specific recovery stage and goals.
What we won't promise
No guarantee of full tissue regrowth
We won't claim a generic infusion replaces infarcted tissue or guarantees speech or walking recovery. We set expectations honestly and track every outcome that matters.
A direct answer
The short answer
Our Istanbul program supports stroke recovery once emergency treatment, secondary prevention, and rehabilitation are underway. We match IV multipotent-cell, marrow-cell, or neural-product protocols to your recovery phase, coordinated with your rehabilitation team.
Start with the phenotype
Stroke type and timing shape your plan
An acute treatment need and a chronic rehabilitation goal call for different plans, and we build yours around exactly where you are in recovery.
The stroke care pathway comes first
Emergency action, secondary prevention, and rehabilitation always take priority — our program supports that pathway rather than competing with it.
- Call emergency services for any new or recurrent stroke symptom
- Use thrombolysis, thrombectomy, hemorrhage control, or neurosurgery when indicated
- Identify the cause and optimize blood pressure, lipids, diabetes, rhythm, smoking, and antithrombotic therapy
- Continue physical, occupational, speech, swallowing, cognitive, and vision rehabilitation
- Address seizures, spasticity, pain, depression, falls, nutrition, caregiver needs, and return to participation
- 01
Acute ischemic stroke
A blocked artery may be eligible for emergency thrombolysis or mechanical thrombectomy after rapid imaging and specialist assessment.
- 02
Hemorrhagic stroke
Bleeding requires blood-pressure, anticoagulation, neurosurgical, and critical-care decisions that differ from ischemic stroke.
- 03
Subacute recovery
Early weeks and months include spontaneous recovery, medical stabilization, and intensive task-specific rehabilitation.
- 04
Chronic disability
Stable motor, language, cognitive, sensory, or visual deficits require goal-specific measurement and different research designs.
Product and route matter
Four routes, matched to your recovery
Stroke-cell protocols differ by product, route, time from onset, and imaging, so we select the combination that fits your recovery phase rather than a one-size answer.
- 01
Intravenous multipotent cells
Acute trials have tested defined allogeneic bone-marrow-derived products for immune-modulatory effects.
Evidence boundaryLarge controlled studies have not established a 90-day functional benefit.
- 02
Autologous marrow cells
Smaller studies use marrow mononuclear or selected cell preparations by IV or arterial delivery.
Evidence boundaryHarvest, dose, route, timing, and comparator vary, and vascular delivery carries procedure-specific risk.
- 03
Intracerebral neural cells
Early studies implant a defined neural-cell line near selected chronic ischemic lesions.
Evidence boundaryThis is neurosurgery, not an infusion, and small open-label studies cannot establish efficacy.
- 04
MSC secretome and exosomes
Acellular signaling products are marketed more quickly than they are clinically validated.
Evidence boundaryNo exosome product is FDA-approved for stroke, and preclinical repair language is not a human outcome.
Indexed evidence ledger
The evidence behind our protocols
Recovery can change quickly after stroke, so we read every trial's randomization, standardized rehabilitation, and predefined endpoints to separate real treatment effect from natural recovery.
01 MASTERS phase 2
Open study- Product
- IV allogeneic multipotent adult progenitor cells
- Study design
- Randomized double-blind placebo-controlled trial, 129 participants randomized
- Finding
- The treatment was generally tolerated but did not improve global stroke recovery at day 90.
- Limitation
- An exploratory earlier-treatment signal requires prospective confirmation and cannot support commercial recovery promises.
02 TREASURE phase 2/3
Open study- Product
- IV allogeneic multipotent adult progenitor cells
- Study design
- Randomized double-blind placebo-controlled trial, 206 adults with acute ischemic stroke
- Finding
- Adverse-event frequency was similar, but the product did not improve the primary excellent-outcome measure at day 90.
- Limitation
- Exploratory subgroups or later observations cannot override the neutral primary efficacy result.
03 PISCES-2
Open study- Product
- Allogeneic human neural stem-cell line implanted into the putamen
- Study design
- Prospective open-label single-arm study, 23 people in subacute-chronic recovery
- Finding
- Demonstrated multicenter surgical feasibility with limited exploratory upper-limb responses.
- Limitation
- No control group, selected ischemic strokes, procedural risk, and only one of 23 met the prespecified arm-test response at three months.
Measure what changes
We track recovery with validated measures
Your endpoints match your deficit, baseline, and phase of recovery, with rehabilitation exposure documented at every step.
- 01
Global disability
Modified Rankin Scale and Barthel Index interpreted with living situation and assistance needs.
- 02
Neurologic deficit
NIH Stroke Scale for defined neurologic domains, especially in acute and subacute studies.
- 03
Domain-specific recovery
Fugl-Meyer, gait, hand function, language, swallowing, cognition, vision, and neglect measures matched to the lesion.
- 04
Safety and recurrence
New stroke, bleeding, seizures, thrombosis, infection, neurologic worsening, procedure events, and medication adherence.
Clinical review before travel
Your free Istanbul medical evaluation
Send us your stroke history, imaging, and rehabilitation progress, and our neurology team confirms medical stability, recovery trajectory, and the right protocol before you travel.
Records to send
- Emergency, hospitalization, discharge, and neurology summaries with stroke date and treatments
- CT, CTA, MRI, angiography, cardiac, and vascular images and reports
- Cause workup, rhythm monitoring, blood pressure, lipids, diabetes, and antithrombotic plan
- mRS, NIHSS, Barthel, Fugl-Meyer, speech, swallowing, cognitive, gait, and hand assessments
- Medication, seizure, bleeding, clot, infection, surgery, and rehabilitation history
Reasons to pause
- Any new or worsening stroke symptom, which requires emergency services immediately
- Unstable blood pressure, bleeding, clotting, infection, seizures, swallowing, cardiac, or respiratory status
- An unreviewed anticoagulant or antiplatelet plan before lumbar, arterial, or surgical procedures
- Any claim that an animal study or testimonial proves human brain-tissue regeneration
Transparent planning
Stroke recovery treatment cost in Istanbul
IV infusion, arterial delivery, and intracerebral surgery are priced as distinct services. Your quote names the product, route, hospital requirements, medication coordination, rehabilitation, and follow-up, plus travel and hotel support.
Our 2026 neurological program band starts from $9,000-$25,000, giving you a transparent baseline confirmed exactly after your free evaluation.
- Neurology, vascular, rehabilitation, imaging, and anesthesia review
- Exact product, dose, route, timing, and release documentation
- Hospital, procedure, bleeding, seizure, and complication support
- Rehabilitation intensity, accessible travel, outcomes, imaging, and follow-up
Questions patients ask before booking
- 01
Which stroke type, recovery phase, cell product, and route match my case?
- 02
What does the program cost, and how many days will I spend in Istanbul?
- 03
How are bleeding, anticoagulants, seizures, infection, and procedure risks managed?
- 04
How will you separate spontaneous recovery and rehabilitation from a treatment effect?
FAQ
Questions about stroke
Call local emergency services immediately. Do not wait for a clinic reply, travel, or a cell-therapy consultation — reperfusion and hemorrhage treatment are time-critical.
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.